Commons Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$447K Buy
1,830
+2
+0.1% +$466 0.37% 49
2025
Q4
$378K Hold
1,828
0.25% 74
2025
Q3
$339K Buy
1,828
+2
+0.1% +$343 0.22% 79
2025
Q2
$279K Buy
1,826
+291
+19% +$44.7K 0.21% 85
2025
Q1
$255K Sell
1,535
-502
-25% -$78.5K 0.23% 75
2024
Q4
$295K Buy
2,037
+93
+5% +$14.4K 0.27% 69
2024
Q3
$315K Sell
1,944
-105
-5% -$16.7K 0.35% 44
2024
Q2
$299K Sell
2,049
-194
-9% -$28.9K 0.36% 37
2024
Q1
$355K Sell
2,243
-25
-1% -$3.98K 0.52% 32
2023
Q4
$356K Sell
2,268
-17
-0.7% -$2.61K 0.56% 34
2023
Q3
$356K Sell
2,285
-206
-8% -$34K 0.61% 35
2023
Q2
$412K Sell
2,491
-604
-20% -$97.5K 0.62% 37
2023
Q1
$480K Sell
3,095
-226
-7% -$36.5K 0.77% 31
2022
Q4
$587K Buy
3,321
+5
+0.2% +$863 0.97% 30
2022
Q3
$542K Sell
3,316
-139
-4% -$23.5K 0.86% 30
2022
Q2
$613K Sell
3,455
-95
-3% -$16.9K 0.93% 31
2022
Q1
$629K Sell
3,550
-592
-14% -$101K 0.68% 32
2021
Q4
$709K Buy
+4,142
New +$678K 0.7% 36

Other funds holding JNJ

Commons Capital's JNJ Position: Q1 2026 in Review

Commons Capital increased its Johnson & Johnson (JNJ) stake by 0.11% in Q1 2026, buying an estimated $466 and bringing the position to 1,830 shares worth $447K. The position accounts for 0.37% of the portfolio, ranked #49.

Commons Capital first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $709K in Q4 2021. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Commons Capital held 1,830 shares of Johnson & Johnson worth $447K as of Q1 2026.
  • Commons Capital bought 2 Johnson & Johnson shares in Q1 2026, an estimated $466.
  • Johnson & Johnson made up 0.37% of Commons Capital's portfolio in Q1 2026, its #49 holding.
  • Commons Capital first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Commons Capital's Johnson & Johnson position peaked at $709K in Q4 2021.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Commons Capital's 13F filing for Q1 2026, filed 30 Apr 2026.